You are here

  • Home
  • Archive
  • Volume 100, Issue 7
  • Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Article metrics

Article menu
Download PDFPDF
Clinical science
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2015 to May 2022

AbstractFullPdf
Nov 20152854259
Dec 201581511
Jan 2016561412
Feb 2016361311
Mar 201640511
Apr 20163479
May 201652618
Jun 20164811670
Jul 20164981658
Aug 20163461036
Sep 2016117618
Oct 2016102521
Nov 2016116672
Dec 20167359
Jan 201713436
Feb 201760919
Mar 2017481512
Apr 20172184
May 2017361311
Jun 2017851411
Jul 20171011314
Aug 20171391011
Sep 20172251117
Oct 2017347138
Nov 20173242819
Dec 2017165377
Jan 2018176285
Feb 2018189278
Mar 2018151289
Apr 2018284365
May 2018150247
Jun 2018110297
Jul 2018120448
Aug 2018124377
Sep 201867346
Oct 201869142
Nov 201874140
Dec 201887171
Jan 201978153
Feb 201957165
Mar 20194554
Apr 20192610
May 201943154
Jun 201948246
Jul 201933192
Aug 201947191
Sep 201965224
Oct 201948182
Nov 201931215
Dec 201937130
Jan 202042202
Feb 202053307
Mar 202077174
Apr 202085214
May 202078214
Jun 202043152
Jul 202075214
Aug 202063173
Sep 202086224
Oct 202047153
Nov 20204641
Dec 20209423
Jan 20218131
Feb 20217243
Mar 20214642
Apr 20214534
May 20212253
Jun 2021444
Jul 2021223
Aug 2021110
Sep 2021553
Oct 20213831
Nov 20214447
Dec 20215333
Jan 20223556
Feb 20224100
Mar 20225532
Apr 20222911
May 20226332
Total75861108741